ENTERA BIO LTD's ticker is and the CUSIP is M40527909. A total of 3 filers reported holding ENTERA BIO LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,677 | -14.7% | 29,900 | 0.0% | 0.00% | – |
Q2 2023 | $25,415 | -26.7% | 29,900 | 0.0% | 0.00% | – |
Q1 2023 | $34,684 | +40.6% | 29,900 | -11.5% | 0.00% | – |
Q4 2022 | $24,674 | -29.5% | 33,800 | 0.0% | 0.00% | – |
Q3 2022 | $35,000 | -22.2% | 33,800 | 0.0% | 0.00% | – |
Q2 2022 | $45,000 | -54.1% | 33,800 | -1.2% | 0.00% | – |
Q1 2022 | $98,000 | -44.0% | 34,200 | -44.9% | 0.00% | – |
Q4 2021 | $175,000 | +218.2% | 62,100 | +430.8% | 0.00% | – |
Q3 2021 | $55,000 | -11.3% | 11,700 | +12.5% | 0.00% | – |
Q2 2021 | $62,000 | – | 10,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 33,800 | $35,000 | 0.00% |
SIMPLEX TRADING, LLC | 1,400 | $1,000 | 0.00% |